The Moving Average Convergence Divergence (MACD) for SKHCF turned positive on January 07, 2025. Looking at past instances where SKHCF's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on January 06, 2025. You may want to consider a long position or call options on SKHCF as a result. In of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
SKHCF moved above its 50-day moving average on January 07, 2025 date and that indicates a change from a downward trend to an upward trend.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where SKHCF advanced for three days, in of 89 cases, the price rose further within the following month. The odds of a continued upward trend are .
SKHCF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where SKHCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.271) is normal, around the industry mean (23.424). P/E Ratio (16.750) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.029) settles around the average of (0.018) among similar stocks. P/S Ratio (1.965) is also within normal values, averaging (41.167).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SKHCF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SKHCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.
Industry MedicalSpecialties
A.I.dvisor tells us that SKHCF and SAUHY have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SKHCF and SAUHY's prices will move in lockstep.
Ticker / NAME | Correlation To SKHCF | 1D Price Change % | ||
---|---|---|---|---|
SKHCF | 100% | +1.68% | ||
SAUHY - SKHCF | 10% Poorly correlated | +1.11% | ||
SAFLY - SKHCF | 9% Poorly correlated | N/A | ||
SAUHF - SKHCF | 6% Poorly correlated | +1.74% | ||
SEMHF - SKHCF | 5% Poorly correlated | -0.18% | ||
SHWGY - SKHCF | 4% Poorly correlated | N/A | ||
More |